Form 4: Thermo Fisher Scientific Director Acquires Phantom Stock Units

Jennifer M. Johnson, a director at Thermo Fisher Scientific, acquired phantom stock units under the company's Deferred Compensation Plan for Directors.

Summary

• Jennifer M. Johnson, a director of Thermo Fisher Scientific, acquired 60.07 phantom stock units on December 31, 2024.
• These units were credited to her account under the company's Deferred Compensation Plan for Directors.
• The units were valued at $520.23 each, based on the closing price of the stock at the end of the quarter.
• The phantom stock units are convertible into common stock on a 1-for-1 basis.
• The shares will be distributed as stock upon cessation of director service or a change of control.
• Ms. Johnson is also the President and CEO of Franklin Resources, Inc., which manages investment products that hold Thermo Fisher Scientific stock, but she disclaims beneficial ownership of those securities.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns director interests with the company's performance.
• The Deferred Compensation Plan for Directors provides a long-term incentive for directors.

Future Outlook

The phantom stock units will be distributed as stock upon cessation of director service or a change of control.

Management Comments

• Reporting Person disclaims beneficial ownership of securities held by Franklin Templeton subsidiaries.

Industry Context

This is a standard transaction for directors of public companies, often used as part of their compensation package to align their interests with shareholders.

Comparison to Industry Standards

• Deferred compensation plans using phantom stock units are common among large public companies like Thermo Fisher Scientific.
• Companies such as Danaher Corporation (DHR) and Agilent Technologies (A) also use similar compensation structures for their directors.
• The value of the units is typically tied to the company's stock price, which is a standard practice.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's long-term performance.

Key Dates

Keywords

Thermo Fisher Scientific, phantom stock units, director compensation, deferred compensation plan, insider trading, Form 4, equity securities